Cardiac allograft vasculopathy. Preferential regulation of endothelial cell-derived mesenchymal growth factors in response to a donor-specific cell-mediated allogeneic response

Transplantation

Volumn 61, Issue 6, 1996, Pages 939-948

  Hosenpud, Jeffrey D ^a,b   Morris, Tony E ^a   Shipley, Gary D ^a   Mauck, Kimberly A ^b   Wagner, Cynthia R ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELLULAR IMMUNITY; ENDOTHELIUM CELL; HEART TRANSPLANTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

BASE SEQUENCE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION; GRAFT OCCLUSION, VASCULAR; HEART TRANSPLANTATION; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHENOTYPE; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; UP-REGULATION;

EID: 0029960848     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199603270-00017     Document Type: Article

References (45)

1. Hosenpud JD, Everett JP, Morris TE, Mauck KA, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: Association with cell-mediated but not humoral allo-immunity to donor-specific vascular endothelium. Circulation 1995; 92: 205.
2. Billingham ME. Cardiac Transplant Atherosclerosis. Transplant Proc 1987; 19: 19.
3. Paavonen T, Mennander A, Lautenschlager I, Mattila S, Hayry P. Endothelialitis and accelerated arteriosclerosis in human heart transplant coronaries. J Heart Lung Transplant 1993; 12: 117.
4. Louie HW, Pang M, Lewis W, Drinkwater DC, Laks H. Immunohistochemical analysis of accelerated graft atherosclerosis in cardiac transplantation. Curr Surg 1989; 46: 479.
5. Hruban RH, Beschorner WE, Baumgartner WA, Augustine SM, Reitz BA, Hutchins GM. Accelerated arteriosclerosis in heart transplant recipients: an immunopathology study of 22 transplanted hearts. Transplant Proc 1991; 23: 1230.
6. Wagner CR, Morris TE, Shipley GD, Hosenpud JD. Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro. J Clin Invest 1993; 92: 1269.
7. Hirschberg H, Evensen SA, Henriksen T, Thorsby E. The human mixed lymphocyte-endothelium culture interaction. Transplantation 1975; 19: 495.
8. Hirschberg H, Bergh OJ, Thorsby E. Antigen-presenting properties of human vascular endothelial cells. J Exp Med 1980; 152: 249.
9. Gao S-Z, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 1988; 12: 334.
10. Hosenpud JD, Shipley GD, Morris TE, Hefeneider SH, Wagner CR. The modulation of human aortic endothelial cell ICAM-1 (CD-54) expression by serum containing high titers of anti-HLA antibodies. Transplantation 1993; 55: 405.
11. Morris TE, Mattox PA, Shipley GD, Wagner CR, Hosenpud JD. The pattern of cytokine messenger RNA expression in human aortic endothelial cells is different from that of human umbilical vein endothelial cells. Transplant Immunol 1993; 1: 137.
12. Yoshizumi M, Kourembanas S, Temizer DH, Cambria RP, Quertermous T, Lee ME. Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. J Biol Chem 1992; 267: 9467.
13. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-line cells that is related to EGF. Science 1991; 251: 936.
14. Ehlers S, Smith KA. Differentiation of T cell lymphokine gene expression: the in vitro aquisition of T cell memory. J Exp Med 1991; 173: 25.
15. Kobashigawa JA, Kirklin JK, Naftel DC, et al. Pre-transplant risk factors for acute rejection after cardiac transplantation: a multi-institutional study. J Heart Lung Transplant 1993; 12: 355.
16. Renlund DG, Gilbert EM, O'Connell JB, et al. Age-associated decline in cardiac allograft rejection. Am J Med 1987; 83: 391.
17. Kirklin JK, Vaftel DC, McGiffin DC, McVay RF, Blackstone EH, Karp RB. Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol 1988; 11: 917.
18. Hosenpud JD, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: current concepts, recent developments and future directions. J Heart Lung Transplant 1992; 11: 9.
19. Libby P, Salomon RN, Payne DD, Schoen FJ, Pober JS. Functions of vascular wall cells related to developments of transplantation-associated coronary arteriosclerosis. Transplant Proc 1989; 21: 3677.
20. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, Tsuruya Y, Kano S. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol 1991; 260: H1713.
21. Morris TE, Shipley GD, Wagner CR, Hefeneider SH, Hosenpud JD. Time course and contact dependence of allogeneic lymphocyte-induced human aortic endothelial cell-derived interleukin-6. J Heart Lung Transplant 1994; 13: 1081.
22. Hajjar KA, Hajjar DP, Silverstein RL, Nachman RL. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med 1987; 166: 235.
23. Suzuki H, Shibano K, Okane M, et al. Interferon-g modulates messenger RNA levels of c-sis (PDGF-B chain), PDGF-A chain, and IL-1β genes in human vascular endothelial cells. Am J Pathol 1989; 134: 35.
24. Shaddy RE, Hansen JC, Cowley CG. Effects of T-cells on platelet-derived growth factor-like protein secretion from endothelial cells. J Heart Lung Transplant 1992; 11: 48.
25. Isik FF, Vaentine HA, McDonald TO, Baird A, Gordon D. Localization of bFGF in human transplant coronary atherosclerosis. Ann N Y Acad Sci 1991; 638: 487.
26. Zhao XM, Yeoh TK, Frist WH, Porterfield SL, Miller GG. Induction of acidic fibroblast growth factor and full-length platelet-derived growth factor expression in human cardiac allografts. Circulation 1994; 90: 677.
27. Zhao XM, Citrin BS, Frist WH, et al. Acidic fibroblast growth factor (aFGF) and untreated mild rejection are associated with the development of cardiac allograft vasculopathy (CAV). Circulation 1994; 90: 1-94.
28. Marikovsky M, Breuing MK, Liu PY, et al. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci USA 1993; 90: 3889.
29. Kume N, Gimbrone MA Jr. Lysophosphatidylcholine trascriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 1994; 93: 907.
30. Besner GE, Whelton D, Crissman-Combs MA, Steffen CL, Kim GY, Brigstock DR. Interaction of heparin-binding EGF-like growth factor (HB-EGF) with epidermal growth factor receptor: modulation by heparin heparinase or synthetic heparine-binding HB-EGF fragments. Growth Factors 1992; 7: 289.
31. Higashiyama S, Abraham JA, Klagsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J Cell Biol 1993; 122: 933.
32. Cook PW, Coffey RJ, Magun BE, Pittelkow MR, Shipley GD. Expression and regulation of mRNA coding for acidic and basic fibroblast growth factor and transforming growth factor α in cells derived from human skin. Mol Endocrinol 1990; 4: 1377.
33. Derynck R. Transforming growth factor α. Cell 1988; 54: 593.
34. Coffey RJ, Derynck R, WIlcox JN, et al. Production and autoinduction of transforming growth factor α in human keratinocytes. Nature 1987; 328: 817.
35. Madtes DK, Raines EW, Sakariassen KS, et al. Induction of transforming growth factor-α in activated human alveolar macrophages. Cell 1988; 53: 285.
36. Schreiber AB, Winkler ME, Derynck R. Transforming growth factor-α: a more potent angiogenic mediator than epidermal growth factor. Science 1986; 232: 1250.
37. Banskota NK, Taub R, Zellner K, King GL. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol 1989; 3: 1183.
38. Hwang DL, Latus LJ, Lev-Ran A. Effects of platelet-containing growth factors (PDGF, EGF, IGF-1 and TGF-beta) on DNA synthesis in porcine aortic smooth muscle cells in culture. Exp Cell Res 1992; 200: 358.
39. Winkles JA, Gay CG. Serum, phorbol ester and polypeptide mitogens increase class I and 2 heparin-binding (acidic and basic fibroblast) growth factor gene expression in human vascular smooth muscle cells. Cell Growth Different 1991; 2: 531.
40. Delafontaine P, Lou H, Alexander RW. Regulation of insulin-like grwoth factor 1 messenger RNA levels in vascular smooth muscle cells. Hypertension 1991; 18: 742.
41. Epstein SE, Siegall CB, Biro S, Fu YM, FitzGerald D, Pastan I. Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells. Circulation 1991; 84: 778.
42. Uretsky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987; 76: 827.
43. Ventura HO, Ramee SR, Jain A, et al. Coronary artery imaging with intravascular ultrasound in patients following cardiac transplantation. Transplantation 1992; 53: 216.
44. St Goar FG, Pinto FJ, Alderman EL et al. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of "angiographically silent" intimal thickening. Circulation 1992; 85: 979.
45. Liu G, Butany J. Morphology of graft arteriosclerosis in cardiac transplant recipients. Hum Pathol 1992; 23: 768.